GF Fund Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.5K Hold
1,502
﹤0.01% 490
2025
Q1
$24.2K Buy
1,502
+270
+22% +$4.36K ﹤0.01% 483
2024
Q4
$28.7K Buy
+1,232
New +$28.7K ﹤0.01% 436